---
scope: administer
---

## Generic Name

naloxone

## Trade Name

Narcan

## Classification

Opioid antagonist

## Indications

Complete or partial reversal of CNS and respiratory depression induced by opioids

## Contraindications

Hypersensitivity

## Precautions

Use with caution in narcotic-dependent patients who may experience withdrawal syndrome (including neonates for narcotic-dependent mothers)

## Side Effects

- Narcotic withdrawal syndrome
- Nausea/vomiting
- Cardiac dysrhythmias
- Hypotension
- Hypertension

## Dose

Titrate to effect:

- Adult IM: 0.4mg m(2mg)
- Adult IN: 1.0mg/nare, q(3-5) prn
- Pediatric: 0.1mg/kg given MI m(2mg)

## Supplied

2 mg in 2 mL vials

## Mechanism

Naloxone is a competitive narcotic antagonist.

It competes for narcotic receptors in the brain and it can also displace narcotic molecules from the receptors.

It can be used to treat narcotics and synthetic narcotic agents.

- Onset in < 2min IV/10, 2-10 min IM/ETT (ETT ALS only)
- Peak effects within < 2min IV/lO, 2-10 min IM/ETT (ETT ALS only)
- Duration of 20-120 min
- 1â„2 life of 60-90min

## Notes

Higher doses of 10 -20 mg may be required for overdoses of synthetic narcotics. Narcan has no real effect when given when narcotics are not present.

Should be used ni caution ni the case of polypharmacy overdoses, though respiratory depression usually the largest issue for administration.
